Holland & Knight has bolstered its Corporate, M&A and Securities Practice Group with the addition of Ibrahim Barakat as a partner in Miami. Mr. Barakat represents public and private corporations, private equity funds and strategic investors in connection with a wide range of transactional and corporate matters. He was previously a partner with McDermott Will & Emery.
"Ibrahim is a very highly regarded attorney whose extensive client base, investment banking and other relationships and experience in private equity and M&A transactions, especially in healthcare, will help strengthen our relationships with current clients and grow our corporate practice," said David Barkus, co-leader of the firm's Corporate, M&A and Securities Practice Group and leader of the firm's Private Equity Team. "Ibrahim's experience with cross-border M&A transactions in Latin America also fits with the firm's strengths and client needs. We are proud to have more than 200 bilingual attorneys in our Latin America practice, with Ibrahim now among them."
"Holland & Knight recently reached a new milestone of more than 200 attorneys in our Miami office, and the addition of a talented attorney such as Ibrahim reaffirms our commitment to remain at the top of the market in the city," said Wifredo Ferrer, executive partner of the firm's Miami office. "Ibrahim is not only a very skilled attorney but also a great cultural fit for the firm who will be a valuable member of our South Florida team."
"I have worked opposite Ibrahim on several transactions over the last decade. His strong skills and significant experience representing healthcare clients in a variety of transactions throughout the U.S. make him a valuable addition to our team," said Brent Hill, leader of Holland & Knight's Healthcare Section. "I look forward to collaborating with Ibrahim and watching him do great things on our platform."
"Holland & Knight's entrepreneurial spirit, platform and deep bench of experienced attorneys, especially in the area of healthcare, are ideal for my clients and make the firm ideally suited for my practice," Mr. Barakat said. "I am excited to contribute to the firm's industry-leading M&A and healthcare practices, and to collaborate with such talented teams. I have long admired Holland & Knight's culture and the HK Deal Flow program, which will be a significant asset to growing my practice and supporting our clients."
Mr. Barakat earned a J.D. degree from Cornell Law School and a B.B.A. degree from the University of Miami.
Recently recognized as the Private Equity Law Firm of the Year by Global M&A Network, Holland & Knight regularly ranks among the leading M&A and private equity law firms in reputable, benchmarking league tables published by Bloomberg, LSEG, Mergermarket, PitchBook and The Deal. The firm is also ranked among the most active law firms in the country for healthcare private equity transactions. Through the HK Deal Flow℠ program, Holland & Knight facilitates deal leads for clients and prospective clients by matching acquisition or capital raising opportunities with buyers and investors.
According to Modern Healthcare, Holland & Knight's Healthcare & Life Sciences Industry Group, a cross-disciplinary team of more than 400 experienced attorneys, is the largest healthcare law practice in the United States.
Original source can be found here.